Table 6.
Disease-Free Survival, Overall Survival Times, Comparative Log Rank Test, p-values Obtained Using Kaplan–Meier Method of TNBC, Luminal A, Luminal B Received Herceptin, Luminal B Did Not Receive Herceptin and HER2-Enriched Received Herceptin, HER2-Enriched Did Not Receive Herceptin Subgroups Forming Subtyping 5
| Subtyping 5 | Mean ± Std. Error (Months) | 95% Confidence Interval | HER2 Negative | Luminal B Received Herceptin | Luminal B Did Not Receive Herceptin | HER2-Enriched Received Herceptin | ||
|---|---|---|---|---|---|---|---|---|
| Lower Bound | Upper Bound | |||||||
| Disease-free survival | HER2 Negative | 225.237±3.89 | 217.60 | 232.86 | ||||
| Luminal B received Herceptin | 126.33±5.10 | 116.32 | 136.34 | 3.006 (0.083) | ||||
| Luminal B did not receive Herceptin | 171.69±4.90 | 162.09 | 181.30 | 1.945 (0.163) | 0.162 (0.688) | |||
| HER2-enriched received Herceptin | 101.50±6.49 | 88.77 | 114.23 | 26.736 (<0.001) | 8.466 (0.004) | 12.783 (<0.001) | ||
| HER2-enriched did not receive Herceptin | 92.79±18,03 | 57.44 | 128.13 | 16.902 (<0.001) | 7.133 (0.008) | 11.736 (0.001) | 1.665 (0.197) | |
| Overall survival | HER2 Negative | 235.49±3.48 | 228.66 | 242.33 | ||||
| Luminal B received Herceptin | 148.32±4.17 | 140.14 | 156.50 | 0.607 (0.436) | ||||
| Luminal B did not receive Herceptin | 178.20±4.91 | 168.56 | 187.84 | 0.386 (0.534) | 0.999 (0.317) | |||
| HER2-enriched received Herceptin | 118.14±6.16 | 106.06 | 130.22 | 18.218 (<0.001) | 14.578 (<0.001) | 11.466 (<0.001) | ||
| HER2-enriched did not receive Herceptin | 94.44±15.23 | 64.58 | 124.30 | 30.150 (<0.001) | 30.660 (<0.001) | 25.569 (<0.001) | 5.602 (0.018) | |
Notes: p values are in italic, significant p values are in bold italic.